Advanced SearchSearch Tips
Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Toxicological Research
  • Volume 32, Issue 2,  2016, pp.133-140
  • Publisher : The Korean Society of Toxicology
  • DOI : 10.5487/TR.2016.32.2.133
 Title & Authors
Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver
Heidari, Reza; Esmailie, Neda; Azarpira, Negar; Najibi, Asma; Niknahad, Hossein;
  PDF(new window)
Sulfasalzine is a widely administered drug against inflammatory-based disorders in human. However several cases of liver injury are associated with its administration. There is no stabilized safe protective agent against sulfasalazine-induced liver injury. Current investigation was designed to evaluate if N-acetylcysteine (NAC) and dithioteritol (DTT) as thiol reducing agents and/or vitamins C and E as antioxidants have any protective effects against sulfasalazine-induced hepatic injury in an ex vivo model of isolated rat liver. Rat liver was canulated and perfused via portal vein in a closed recirculating system. Different concentrations of sulfasalazine and/or thiol reductants and antioxidants were administered and markers of organ injury were monitored at different time intervals. It was found that 5 mM of sulfasalazine caused marked liver injury as judged by rise in liver perfusate level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) (p < 0.05). A significant amount of lipid peroxidation and hepatic glutathione depletion were detected in drug-treated livers, accompanied with significant histopathological changes of the organ. Administration of NAC (), DTT (), Vitamin C (), or vitamin E () significantly alleviated sulfasalazine-induced hepatic injury in isolated perfused rat liver. The data obtained from current investigation indicate potential therapeutic properties of thiol reductants and antioxidants against sulfasalazine-induced liver injury.
Dithioteritol;Drug-induced liver injury (DILI);Glutathione;Hepatoprotection;N-acetyl cysteine;Oxidative stress;
 Cited by
Topical tocopherol for treatment of reticular oral lichen planus: a randomized, double-blind, crossover study, Oral Diseases, 2016  crossref(new windwow)
Holt, M.P. and Ju, C. (2006) Mechanisms of drug-induced liver injury. AAPS J., 8, E48-E54. crossref(new window)

Abdoli, N., Heidari, R., Azarmi, Y. and Eghbal, M.A. (2013) Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J. Biochem. Mol. Toxicol., 27, 287-294. crossref(new window)

Heidari, R., Niknahad, H., Jamshidzadeh, A. and Abdoli, N. (2014) Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin. Mol. Hepatol., 20, 237-248. crossref(new window)

Heidari, R., Niknahad, H., Jamshidzadeh, A., Eghbal, M.A. and Abdoli, N. (2015) An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv. Pharm. Bull., 5, 1-11.

Rains, C.P., Noble, S. and Faulds, D. (1995) Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs, 50, 137-156. crossref(new window)

de Abajo, F.J., Montero, D., Madurga, M. and Garcia Rodriguez, L.A. (2004) Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br. J. Clin. Pharmacol., 58, 71-80. crossref(new window)

Khokhar, O.S. and Lewis, J.H. (2010) Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig. Dis., 28, 508-518. crossref(new window)

Marinos, G., Riley, J., Painter, D.M. and McCaughan, G.W. (1992) Sulfasalazine-induced fulminant hepatic failure. J. Clin. Gastroenterol., 14, 132-135. crossref(new window)

Rubin, R. (1994) Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am. J. Gastroenterol., 89, 789-91.

Ransford, R.A. and Langman, M.J. (2002) Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the committee on safety of medicines. Gut, 51, 536-539. crossref(new window)

Jobanputra, P., Amarasena, R., Maggs, F., Homer, D., Bowman, S., Rankin, E., Filer, A., Raza, K. and Jubb, R. (2008) Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events. BMC Musculoskelet. Disord., 9, 48. crossref(new window)

Linares, V., Alonso, V., Albina, M.L., Belles, M., Sirvent, J.J., Domingo, J.L. and Sanchez, D.J. (2009) Lipid peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine. Toxicology, 256, 152-156. crossref(new window)

Linares, V., Alonso, V. and Domingo, J.L. (2011) Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin. Drug Saf., 10, 253-263. crossref(new window)

Alonso, V., Linares, V., Belles, M., Albina, M.L., Sirvent, J.J., Domingo, J.L. and Sanchez, D.J. (2009) Sulfasalazine induced oxidative stress: A possible mechanism of male infertility. Reprod. Toxicol., 27, 35-40. crossref(new window)

Wolkoff, A.W., Johansen, K.L. and Goeser, T. (1987) The isolated perfused rat liver: preparation and application. Anal. Biochem., 167, 1-14. crossref(new window)

Ferrigno, A., Richelmi, P. and Vairetti, M. (2013) Troubleshooting and improving the mouse and rat isolated perfused liver preparation. J. Pharmacol. Toxicol. Methods, 67, 107-114. crossref(new window)

Bessems, M., 't Hart, N.A., Tolba, R., Doorschodt, B.M., Leuvenink, H.G., Ploeg, R.J., Minor, T. and van Gulik, T.M. (2006) The isolated perfused rat liver: standardization of a time-honoured model. Lab. Anim., 40, 236-246. crossref(new window)

Heidari, R., Jamshidzadeh, A., Keshavarz, N. and Azarpira, N. (2015) Mitigation of methimazole-induced hepatic injury by taurine in mice. Sci. Pharm., 83, 143-158. crossref(new window)

Heidari, R., Babaei, H. and Eghbal, M.A. (2013) cytoprotective effects of organosulfur compounds against methimazoleinduced toxicity in isolated rat hepatocytes. Adv. Pharm. Bull., 3, 135-142.

Sedlak, J. and Lindsay, R.H. (1968) estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem., 25, 192-205. crossref(new window)

Heidari, R., Babaei, H., Roshangar, L. and Eghbal, M.A. (2014) Effects of enzyme induction and/or glutathione depletion on methimazole-induced hepatotoxicity in mice and the protective role of N-acetylcysteine. Adv. Pharm. Bull., 4, 21-28.

Gabay, C., De Bandt, M. and Palazzo, E. (1993) Sulphasalazine-related life-threatening side effects: is N-acetylcysteine of therapeutic value? Clin. Exp. Rheumatol., 11, 417-20.

Sleire, L., Skeie, B.S., Netland, I.A., Forde, H.E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J.I., Pedersen, P.H., Wang, J. and Enger, P.O. (2015) Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system $xc^-$, leading to glutathione depletion. Oncogene, 34, 5951-5959. crossref(new window)

Plosker, G.L. and Croom, K.F. (2005) Sulfasalazine: a review of its use in the management of rheumatoid arthritis. Drugs, 65, 1825-1849. crossref(new window)

Makarova, S.I. (2008) Human N-acetyltransferases and druginduced hepatotoxicity. Curr. Drug Metab., 9, 538-545. crossref(new window)

Wahl, C., Liptay, S., Adler, G. and Schmid, R.M. (1998) Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest., 101, 1163-1174. crossref(new window)

Liptay, S., Bachem, M., Hacker, G., Adler, G., Debatin, K.M. and Schmid, R.M. (1999) Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br. J. Pharmacol., 128, 1361-1369. crossref(new window)

Yamamoto, Y. and Gaynor, R.B. (2001) Therapeutic potential of inhibition of the NF-${\kappa}$B pathway in the treatment of inflammation and cancer. J. Clin. Invest., 107, 135-142. crossref(new window)

Karin, M. and Lin, A. (2002) NF-${\kappa}$B at the crossroads of life and death. Nat. Immunol., 3, 221-227.

Mihas, A.A., Goldenberg, D.J. and Slaughter, R.L. (1978) Sulfasalazine toxic reactions: hepatitis, fever, and skin rash with hypocomplementemia and immune complexes. JAMA, 239, 2590-2591. crossref(new window)

Boyer, D.L., Li, B.U., Fyda, J.N. and Friedman, R.A. (1989) Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr., 8, 528-532. crossref(new window)